Evidence map›Paper›PMID 40109245›Full record

ArticleJournal of pediatric endocrinology & metabolism : JPEM2025

Coexistence of

Ayse Ozden, Hakan Doneray, Ayberk Turkyilmaz, Binali Firinci

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of pediatric endocrinology & metabolism : JPEM, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Functional and structural characterization ofFrontiers in endocrinology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ayse OzdenDepartment of Pediatric Endocrinology, Faculty of Medicine, Ataturk University, Erzurum, Türkiye.ORCID https://orcid.org/0000-0002-3625-2387
Hakan DonerayDepartment of Pediatric Endocrinology, Faculty of Medicine, Ataturk University, Erzurum, Türkiye.ORCID https://orcid.org/0000-0002-9774-3649
Ayberk TurkyilmazDepartment of Medical Genetics, Erzurum Regional Research and Training Hospital, Erzurum, Türkiye.ORCID https://orcid.org/0000-0001-9647-8970
Binali FirinciDepartment of Child Surgery, Faculty of Medicine, Ataturk University, Erzurum, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesHere we present a case of 46,XY disorder of sex development (DSD) in which three variants were detected in the CASE PRESENTATION: A patient with 46,XY karyotype and female phenotype presented at 15 years 3 months of age due to absence of puberty. She exhibited facial signs such as midfacial hypoplasia, long face, proptosis, bulbous nose, mild prognathism and skeletal signs such as scoliosis, pectus carinatum, arachnodactyly and her sex development remained prepubertal. The patient was found to have hypergonadotropic hypogonadism, elevation of 17-OH progesterone and progesterone levels, low anti-mullerian hormone and inhibin B levels, and absence of gonads and a hypoplastic uterus on pelvic ultrasound. Whole exome sequencing revealed a novel hemizygous missense variant in the

conclusionsOur patient is the first case in which the coexistence of variants in the

Indexed as

DEAD-box RNA HelicasesDisorder of Sex Development, 46,XYSex-Determining Region Y ProteinAdolescentFemaleHumansMutation, MissensePrognosisDEAD-box RNA HelicasesSex-Determining Region Y ProteinSRY protein, human46 XY DSDDHX37PORSRY

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.